Clinical Trial Update: Flavopiridol in Treating Patients With Recurrent, Locally Advanced, or Metastatic Soft Tissue Sarcoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating flavopiridol for recurrent, locally advanced, or metastatic soft tissue sarcoma has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma

Drugs mentioned

• Flavopiridol (alvocidib)

Snippet

Sponsor: NCIC Clinical Trials Group | Conditions: Sarcoma | Phase 2 | Status: COMPLETED